KALIPROFEN LA 50 mg/ml raztopina za injiciranje za govedo
  • CARPROFEN
  • Valid
Authorised in these countries:
  • Slovenia
Export to PDF

Product identification

Medicine name:
KALIPROFEN LA 50 mg/ml raztopina za injiciranje za govedo
Active substance and strength:
  • CARPROFEN
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QM01AE91
Authorisation number:
  • NP/V/0418/001
Product identification number:
  • e313f515-0508-4199-9902-ccafb7030d0f
Permanent identification number:
  • 600000015489

Product details

Legal status of supply:
This information is not available for this product.
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • Meat and offal
        21
        day
      • Milk
        0
        hour
  • Intravenous use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        21
        day

Availability

Package description:
Manufacturing sites for batch release:
  • EN- Genera Inc.
Source wholesaler:
This information is not available for this product.
Destination wholesaler:
This information is not available for this product.

Authorisation details

Authorisation status:
  • Valid
Authorisation procedure type:
  • Marketing Authorisation
Procedure number:
  • 2000-6/2011
Date of authorisation status change:
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Authorisation country:
  • Slovenia
Responsible authority:
  • JAZMP
Marketing authorisation holder:
  • Genera SI Podjetje Za Zastopanje In Trgovino d.o.o.
Marketing authorisation issued:
Reference member state:
This information is not available for this product.
Concerned member states:
This information is not available for this product.
Reference product identifier:
This information is not available for this product.
Source product identifier:
This information is not available for this product.

Additional information

To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet

Documents

Summary of Product Characteristics (PDF)
First published:
Last updated:
Package Leaflet and Labelling (PDF)
First published:
Last updated:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."